首页> 外文期刊>International Journal of Medicinal Mushrooms >Efficient Accumulation and In Vitro Antitumor Activities of Triterpene Acids from Submerged Batch-Cultured Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes)
【24h】

Efficient Accumulation and In Vitro Antitumor Activities of Triterpene Acids from Submerged Batch-Cultured Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes)

机译:来自淹没批量培养的凌珠或雷希米药用蘑菇,灵芝(姬松茸)的高效积累和体外抗肿瘤活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Triterpene acids are among the major bioactive constituents of Ganoderma lucidum. However, submerged fermentation techniques for isolating triterpene acids from G. lucidum have not been optimized for commercial use, and the antitumor activity of the mycelial triterpene acids needs to be further proven. The aim of this work was to optimize the conditions for G. lucidum culture with respect to triterpene acid production, scaling up the process, and examining the in vitro antitumor activity of mycelial triterpene acids. The key conditions (i.e., initial pH, fermentation temperature, and rotation speed) were optimized using response surface methodology, and the in vitro antitumor activity was evaluated using the MTT method. The optimum key fermentation conditions for triterpene acid production were pH 6.0; rotation speed, 161.9 rpm; and temperature, 30.1 degrees C, resulting in a triterpene acid yield of 291.0 mg/L in the validation experiment in a 5-L stirred bioreactor; this yield represented a 70.8% increase in titer compared with the nonoptimized conditions. Furthermore, the optimized conditions were then successfully scaled up to a production scale of 200 L, and a triterpene productivity of 47.9 mg/L/day was achieved, which is, to our knowledge, the highest reported in the large-scale fermentation of G. lucidum. In addition, the mycelial triterpene acids were found to be cytotoxic to the SMMC-7721 and SW620 cell lines in vitro. Chemical analysis showed that the key active triterpene acid compounds, ganoderic acids T and Me, predominated in the extract, at 69.2 and 41.6 mg/g, respectively. Thus, this work develops a simple and feasible batch fermentation technique for the large-scale production of antitumor triterpene acids from G. lucidum.
机译:三萜酸是灵霉菌的主要生物活性成分之一。然而,用于将来自G. lucidum的分离的浸没式发酵技术没有针对商业用途进行了优化,并且需要进一步证明菌丝体三萜酸的抗肿瘤活性。这项工作的目的是优化与三萜酸生产的G. lucidum培养的条件,缩放过程,以及检查菌丝体三萜酸的体外抗肿瘤活性。使用响应表面方法优化关键条件(即初始pH,发酵温度和转速),使用MTT方法评价体外抗肿瘤活性。三萜酸生产的最佳关键发酵条件是pH6.0;转速,161.9 rpm;和温度,30.1℃,在5 -L搅拌生物反应器中验证实验中的291.0mg / L的三萜酸产率;与非优化条件相比,该产量表示滴度增加70.8%。此外,然后将优化的条件成功缩放到200L的生产量表,实现了47.9mg / L /天的三萜级生产率,这是我们的知识,这是G的大规模发酵中的最高报告。Lucidum。此外,发现菌丝体三萜酸对SMMC-7721和SW620细胞系中的细胞毒性。化学分析表明,关键活性三萜酸化合物,环氮酸T和ME,分别以69.2和41.6mg / g占优势。因此,这项工作开发了一种简单而可行的批量发酵技术,用于来自G. lucidum的抗肿瘤三萜酸的大规模生产。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号